Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?

Abstract Background Seronegative ocular myasthenia gravis (OMG) is diagnosed by ocular symptoms with supporting SFEMG, typically of frontalis or extensor digitorum muscles. We aimed to determine the sensitivity and specificity of orbicularis oculi SFEMG to diagnose and exclude myasthenia gravis and...

Full description

Bibliographic Details
Main Authors: Goran Rakocevic, Mark Moster, Mary Kay Floeter
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Neurology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12883-017-0891-5
_version_ 1819093186315812864
author Goran Rakocevic
Mark Moster
Mary Kay Floeter
author_facet Goran Rakocevic
Mark Moster
Mary Kay Floeter
author_sort Goran Rakocevic
collection DOAJ
description Abstract Background Seronegative ocular myasthenia gravis (OMG) is diagnosed by ocular symptoms with supporting SFEMG, typically of frontalis or extensor digitorum muscles. We aimed to determine the sensitivity and specificity of orbicularis oculi SFEMG to diagnose and exclude myasthenia gravis and predict response to therapy. Methods Orbicularis oculi SFEMG studies were conducted in 142 consecutive patients with symptoms and/or findings of OMG and negative AChR antibody during the period of 5 years. Retrospective chart review was conducted 2 years after the SFEMG to determine whether treatments were given and responses to treatment. Results Orbicularis oculi SFEMG was abnormal in 31 patients and normal in 111 patients. Twenty-nine patients with abnormal SFEMG were treated, and 25 had a good response. Twenty-four patients with normal SFEMG received treatment; none responded to treatment or developed generalized myasthenia. Conclusion An abnormal orbicularis oculi SFEMG in patients with seronegative OMG has a high predictive value for response to therapy. Our study findings may affect the treatment decisions in practice and aid better management of myasthenic patients.
first_indexed 2024-12-21T23:07:30Z
format Article
id doaj.art-d806c31e248747aa8b88bfae5551a18c
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-12-21T23:07:30Z
publishDate 2017-06-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-d806c31e248747aa8b88bfae5551a18c2022-12-21T18:47:08ZengBMCBMC Neurology1471-23772017-06-011711310.1186/s12883-017-0891-5Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?Goran Rakocevic0Mark Moster1Mary Kay Floeter2Department of Neurology, Thomas Jefferson UniversityWills Eye Hospital, Thomas Jefferson UniversityEMG Section, National Institute of Neurological Disorders and Stroke, National Institutes of HealthAbstract Background Seronegative ocular myasthenia gravis (OMG) is diagnosed by ocular symptoms with supporting SFEMG, typically of frontalis or extensor digitorum muscles. We aimed to determine the sensitivity and specificity of orbicularis oculi SFEMG to diagnose and exclude myasthenia gravis and predict response to therapy. Methods Orbicularis oculi SFEMG studies were conducted in 142 consecutive patients with symptoms and/or findings of OMG and negative AChR antibody during the period of 5 years. Retrospective chart review was conducted 2 years after the SFEMG to determine whether treatments were given and responses to treatment. Results Orbicularis oculi SFEMG was abnormal in 31 patients and normal in 111 patients. Twenty-nine patients with abnormal SFEMG were treated, and 25 had a good response. Twenty-four patients with normal SFEMG received treatment; none responded to treatment or developed generalized myasthenia. Conclusion An abnormal orbicularis oculi SFEMG in patients with seronegative OMG has a high predictive value for response to therapy. Our study findings may affect the treatment decisions in practice and aid better management of myasthenic patients.http://link.springer.com/article/10.1186/s12883-017-0891-5PtosisDiplopiaSingle-fiber EMGNeuromuscular jitterAcetylcholine receptor antibody
spellingShingle Goran Rakocevic
Mark Moster
Mary Kay Floeter
Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?
BMC Neurology
Ptosis
Diplopia
Single-fiber EMG
Neuromuscular jitter
Acetylcholine receptor antibody
title Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?
title_full Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?
title_fullStr Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?
title_full_unstemmed Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?
title_short Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?
title_sort single fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms does abnormal jitter predict response to treatment
topic Ptosis
Diplopia
Single-fiber EMG
Neuromuscular jitter
Acetylcholine receptor antibody
url http://link.springer.com/article/10.1186/s12883-017-0891-5
work_keys_str_mv AT goranrakocevic singlefiberelectromyographyintheorbicularisoculimuscleinpatientswithocularmyastheniagravissymptomsdoesabnormaljitterpredictresponsetotreatment
AT markmoster singlefiberelectromyographyintheorbicularisoculimuscleinpatientswithocularmyastheniagravissymptomsdoesabnormaljitterpredictresponsetotreatment
AT marykayfloeter singlefiberelectromyographyintheorbicularisoculimuscleinpatientswithocularmyastheniagravissymptomsdoesabnormaljitterpredictresponsetotreatment